glp-1 masld Beyond glucagon-like peptide-1: The promise of polyagonists in metabolic dysfunction–associated steatotic liver disease and metabolic dysfunction–associated steatohepatitis—A systematic review of randomized trials Role of glucagon-like peptide-1 receptor

TRIUMPH-4: Osteoarthritis pain signal Because TRIUMPH-4 specifically enrolled participants with symptomatic knee osteoarthritis, it also collected WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) pain data

Theyre also approved for people with a BMI of 27 and at least one weight-related condition, like high blood pressure, high cholesterol, polycystic ovary syndrome (PCOS), or prediabetes

The phase 2 trial ran for 48 weeks total, and the weight loss curve had not fully plateaued by that point, suggesting continued benefits beyond the trial period

I originally set a goal of 150 lbs, and Ive already surpassed it

The MDWatch teams dedication and encouragement have truly changed my life, and I couldnt be more grateful for the lasting impact this program has had on my health and well-being